Brief: Bioarctic Updates Regarding Rumors Of Imminent Approval Of Lecanemab In Great Britain
Aug 22 (Reuters) - BioArctic AB BIOAb.ST :
* REGARDING RUMORS OF AN IMMINENT APPROVAL OF LECANEMAB IN
GREAT
BRITAIN
* COMPANY HAS CURRENTLY NOT BEEN INFORMED THAT RELEVANT
AUTHORITIES HAVE MADE A DECISION AND CANNOT THEREFORE COMMENT ON
THESE RUMORS
* COMPANY WILL UPDATE MARKET IF NEW INFORMATION BECOMES
AVAILABLE
Source text for Eikon: ID:nWkr87vbNy
Further company coverage: BIOAb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million